Frequencies for first 10,000 rows of indi_pt variable in indi2014q2 dataset : 'Preferred Term'-level medical | terminology describing the Indication | for use | Freq. Percent Cum. ----------------------------------------+----------------------------------- 5q minus syndrome | 1 0.01 0.01 Abdominal discomfort | 23 0.23 0.24 Abdominal distension | 3 0.03 0.27 Abdominal pain | 11 0.11 0.38 Abdominal pain upper | 17 0.17 0.55 Abnormal faeces | 1 0.01 0.56 Abnormal sensation in eye | 2 0.02 0.58 Acne | 106 1.06 1.64 Acne cystic | 8 0.08 1.72 Acquired oesophageal web | 2 0.02 1.74 Acromegaly | 6 0.06 1.80 Acute HIV infection | 6 0.06 1.86 Acute coronary syndrome | 3 0.03 1.89 Acute graft versus host disease | 4 0.04 1.93 Acute leukaemia | 4 0.04 1.97 Acute lymphocytic leukaemia | 1 0.01 1.98 Acute myeloid leukaemia | 9 0.09 2.07 Acute myocardial infarction | 1 0.01 2.08 Acute respiratory distress syndrome | 1 0.01 2.09 Addison's disease | 1 0.01 2.10 Adjuvant therapy | 1 0.01 2.11 Adult T-cell lymphoma/leukaemia | 10 0.10 2.21 Affective disorder | 53 0.53 2.74 Age-related macular degeneration | 2 0.02 2.76 Agitation | 2 0.02 2.78 Alopecia | 5 0.05 2.83 Amnesia | 1 0.01 2.84 Amyloidosis | 4 0.04 2.88 Anaemia | 14 0.14 3.02 Anaemia of malignant disease | 1 0.01 3.03 Anaemia prophylaxis | 1 0.01 3.04 Anaemia vitamin B12 deficiency | 1 0.01 3.05 Analgesic therapy | 5 0.05 3.10 Anaphylactic reaction | 1 0.01 3.11 Androgenetic alopecia | 4 0.04 3.15 Angina pectoris | 11 0.11 3.26 Angiopathy | 2 0.02 3.28 Ankylosing spondylitis | 8 0.08 3.36 Anoxia | 1 0.01 3.37 Antacid therapy | 1 0.01 3.38 Antiallergic therapy | 1 0.01 3.39 Antibiotic prophylaxis | 8 0.08 3.47 Antibiotic therapy | 3 0.03 3.50 Anticoagulant therapy | 46 0.46 3.96 Antidepressant therapy | 4 0.04 4.00 Antifungal prophylaxis | 3 0.03 4.03 Antiphospholipid antibodies positive | 3 0.03 4.06 Antiphospholipid syndrome | 2 0.02 4.08 Antiplatelet therapy | 4 0.04 4.12 Antiretroviral therapy | 1 0.01 4.13 Antiviral prophylaxis | 4 0.04 4.17 Antiviral treatment | 1 0.01 4.18 Anxiety | 82 0.82 5.00 Anxiolytic therapy | 1 0.01 5.01 Apathy | 1 0.01 5.02 Aplastic anaemia | 4 0.04 5.06 Appetite disorder | 1 0.01 5.07 Arrhythmia | 3 0.03 5.10 Arrhythmia supraventricular | 1 0.01 5.11 Arthralgia | 15 0.15 5.26 Arthritis | 24 0.24 5.50 Arthropathy | 2 0.02 5.52 Arthropod sting | 1 0.01 5.53 Ascites | 1 0.01 5.54 Aspiration bone marrow | 1 0.01 5.55 Asthenia | 3 0.03 5.58 Asthma | 92 0.92 6.50 Asthma prophylaxis | 2 0.02 6.52 Astrocytoma, low grade | 1 0.01 6.53 Atrial fibrillation | 62 0.62 7.15 Atrial flutter | 1 0.01 7.16 Attention deficit/hyperactivity disor.. | 20 0.20 7.36 Autoimmune disorder | 1 0.01 7.37 B precursor type acute leukaemia | 6 0.06 7.43 B-cell lymphoma | 10 0.10 7.53 Back injury | 2 0.02 7.55 Back pain | 38 0.38 7.93 Barrett's oesophagus | 29 0.29 8.22 Basedow's disease | 2 0.02 8.24 Behcet's syndrome | 14 0.14 8.38 Benign prostatic hyperplasia | 5 0.05 8.43 Bipolar I disorder | 23 0.23 8.66 Bipolar disorder | 76 0.76 9.42 Bladder cancer | 3 0.03 9.45 Bladder disorder | 3 0.03 9.48 Bladder spasm | 2 0.02 9.50 Bladder transitional cell carcinoma | 1 0.01 9.51 Blepharitis | 1 0.01 9.52 Blood cholesterol | 18 0.18 9.70 Blood cholesterol abnormal | 44 0.44 10.14 Blood cholesterol increased | 60 0.60 10.74 Blood copper decreased | 1 0.01 10.75 Blood disorder | 5 0.05 10.80 Blood glucose abnormal | 7 0.07 10.87 Blood growth hormone decreased | 1 0.01 10.88 Blood immunoglobulin M increased | 1 0.01 10.89 Blood iron abnormal | 1 0.01 10.90 Blood iron decreased | 3 0.03 10.93 Blood iron increased | 1 0.01 10.94 Blood magnesium decreased | 1 0.01 10.95 Blood phosphorus increased | 1 0.01 10.96 Blood potassium | 2 0.02 10.98 Blood potassium abnormal | 1 0.01 10.99 Blood pressure | 23 0.23 11.22 Blood pressure abnormal | 88 0.88 12.10 Blood pressure increased | 3 0.03 12.13 Blood testosterone decreased | 1 0.01 12.14 Blood triglycerides | 1 0.01 12.15 Blood triglycerides abnormal | 1 0.01 12.16 Blood triglycerides increased | 5 0.05 12.21 Blood uric acid increased | 1 0.01 12.22 Bone density decreased | 1 0.01 12.23 Bone disorder | 11 0.11 12.34 Bone loss | 7 0.07 12.41 Bone marrow conditioning regimen | 2 0.02 12.43 Bone marrow failure | 1 0.01 12.44 Bone pain | 5 0.05 12.49 Brain neoplasm benign | 2 0.02 12.51 Breakthrough pain | 1 0.01 12.52 Breast abscess | 1 0.01 12.53 Breast cancer | 52 0.52 13.05 Breast cancer female | 3 0.03 13.08 Breast cancer metastatic | 23 0.23 13.31 Bronchial hyperreactivity | 3 0.03 13.34 Bronchitis | 5 0.05 13.39 Bronchitis chronic | 3 0.03 13.42 Bronchopulmonary aspergillosis | 1 0.01 13.43 Budd-Chiari syndrome | 1 0.01 13.44 Burkitt's leukaemia | 37 0.37 13.81 Burkitt's lymphoma | 39 0.39 14.20 Burning sensation | 1 0.01 14.21 Calcium deficiency | 1 0.01 14.22 Cancer pain | 8 0.08 14.30 Candida infection | 2 0.02 14.32 Carcinoid syndrome | 1 0.01 14.33 Carcinoid tumour | 3 0.03 14.36 Cardiac arrest | 10 0.10 14.46 Cardiac disorder | 64 0.64 15.10 Cardiac failure | 20 0.20 15.30 Cardiac failure chronic | 26 0.26 15.56 Cardiac failure congestive | 3 0.03 15.59 Cardiac fibrillation | 1 0.01 15.60 Cardiotoxicity | 2 0.02 15.62 Cardiovascular disorder | 2 0.02 15.64 Cardiovascular event prophylaxis | 6 0.06 15.70 Cataplexy | 4 0.04 15.74 Catatonia | 1 0.01 15.75 Cellulitis | 5 0.05 15.80 Central obesity | 1 0.01 15.81 Cerebrovascular accident | 3 0.03 15.84 Cerebrovascular accident prophylaxis | 2 0.02 15.86 Cervix carcinoma | 2 0.02 15.88 Chest pain | 15 0.15 16.03 Chills | 1 0.01 16.04 Choking | 3 0.03 16.07 Cholangitis | 3 0.03 16.10 Chronic fatigue syndrome | 1 0.01 16.11 Chronic hepatitis B | 4 0.04 16.15 Chronic hepatitis C | 17 0.17 16.32 Chronic infantile neurological cutane.. | 1 0.01 16.33 Chronic lymphocytic leukaemia | 30 0.30 16.63 Chronic myeloid leukaemia | 37 0.37 17.00 Chronic myeloid leukaemia transformat.. | 1 0.01 17.01 Chronic myelomonocytic leukaemia | 2 0.02 17.03 Chronic obstructive pulmonary disease | 53 0.53 17.56 Clostridium difficile infection | 3 0.03 17.59 Cluster headache | 1 0.01 17.60 Coagulopathy | 4 0.04 17.64 Colitis | 14 0.14 17.78 Colitis microscopic | 6 0.06 17.84 Colitis ulcerative | 44 0.44 18.28 Colon cancer | 3 0.03 18.31 Colon cancer metastatic | 7 0.07 18.38 Colon operation | 1 0.01 18.39 Colonic pseudo-obstruction | 1 0.01 18.40 Colonoscopy | 45 0.45 18.85 Colorectal cancer | 3 0.03 18.88 Colorectal cancer metastatic | 9 0.09 18.97 Completed suicide | 1 0.01 18.98 Complex partial seizures | 1 0.01 18.99 Complex regional pain syndrome | 1 0.01 19.00 Compression fracture | 2 0.02 19.02 Computerised tomogram | 3 0.03 19.05 Computerised tomogram abdomen | 1 0.01 19.06 Condition aggravated | 1 0.01 19.07 Conjunctivitis | 3 0.03 19.10 Conjunctivitis allergic | 2 0.02 19.12 Constipation | 36 0.36 19.48 Contraception | 74 0.74 20.22 Contusion | 2 0.02 20.24 Convulsion | 50 0.50 20.74 Convulsion prophylaxis | 3 0.03 20.77 Cord blood transplant therapy | 3 0.03 20.80 Coronary artery disease | 9 0.09 20.89 Costochondritis | 1 0.01 20.90 Cough | 11 0.11 21.01 Crohn's disease | 83 0.83 21.84 Crying | 2 0.02 21.86 Cyclic vomiting syndrome | 1 0.01 21.87 Cystic fibrosis | 3 0.03 21.90 Cystinosis | 2 0.02 21.92 Decreased appetite | 2 0.02 21.94 Decubitus ulcer | 2 0.02 21.96 Deep vein thrombosis | 4 0.04 22.00 Dehydration | 2 0.02 22.02 Delirium | 5 0.05 22.07 Dementia | 2 0.02 22.09 Dementia Alzheimer's type | 4 0.04 22.13 Depressed mood | 1 0.01 22.14 Depression | 142 1.42 23.56 Dermatitis acneiform | 1 0.01 23.57 Dermatitis atopic | 2 0.02 23.59 Dermatomyositis | 3 0.03 23.62 Diabetes mellitus | 276 2.76 26.38 Diabetic nephropathy | 1 0.01 26.39 Diabetic neuropathy | 5 0.05 26.44 Diabetic retinal oedema | 1 0.01 26.45 Diarrhoea | 10 0.10 26.55 Diffuse large B-cell lymphoma | 8 0.08 26.63 Diffuse large B-cell lymphoma recurrent | 4 0.04 26.67 Discomfort | 1 0.01 26.68 Disseminated intravascular coagulation | 2 0.02 26.70 Disseminated tuberculosis | 6 0.06 26.76 Disturbance in attention | 1 0.01 26.77 Diuretic therapy | 14 0.14 26.91 Dizziness | 4 0.04 26.95 Drooling | 1 0.01 26.96 Drug abuse | 3 0.03 26.99 Drug dependence | 4 0.04 27.03 Drug therapy | 2 0.02 27.05 Drug toxicity prophylaxis | 1 0.01 27.06 Dry eye | 3 0.03 27.09 Dry skin | 2 0.02 27.11 Dyslipidaemia | 6 0.06 27.17 Dysmenorrhoea | 9 0.09 27.26 Dyspepsia | 131 1.31 28.57 Dysphagia | 3 0.03 28.60 Dyspnoea | 21 0.21 28.81 Dystonia | 1 0.01 28.82 Dysuria | 1 0.01 28.83 Ear disorder | 1 0.01 28.84 Ear infection | 1 0.01 28.85 Ear pain | 1 0.01 28.86 Effusion | 1 0.01 28.87 Electrolyte substitution therapy | 8 0.08 28.95 Embolism | 1 0.01 28.96 Emphysema | 4 0.04 29.00 Endocarditis | 4 0.04 29.04 Endocarditis staphylococcal | 3 0.03 29.07 Endometriosis | 8 0.08 29.15 Endotracheal intubation | 2 0.02 29.17 Epilepsy | 93 0.93 30.10 Erectile dysfunction | 6 0.06 30.16 Erosive oesophagitis | 8 0.08 30.24 Erythrodermic psoriasis | 2 0.02 30.26 Essential hypertension | 1 0.01 30.27 Essential thrombocythaemia | 5 0.05 30.32 Essential tremor | 1 0.01 30.33 Ex-tobacco user | 1 0.01 30.34 Exposure during pregnancy | 13 0.13 30.47 Extrasystoles | 1 0.01 30.48 Eye disorder | 4 0.04 30.52 Eye swelling | 1 0.01 30.53 Failure to thrive | 1 0.01 30.54 Fallot's tetralogy | 2 0.02 30.56 Familial risk factor | 1 0.01 30.57 Fatigue | 4 0.04 30.61 Febrile convulsion | 1 0.01 30.62 Febrile neutropenia | 2 0.02 30.64 Fibromyalgia | 25 0.25 30.89 Fistula | 1 0.01 30.90 Flatulence | 7 0.07 30.97 Fluid replacement | 4 0.04 31.01 Fluid retention | 8 0.08 31.09 Foetal exposure during pregnancy | 10 0.10 31.19 Folate deficiency | 2 0.02 31.21 Food allergy | 1 0.01 31.22 Furuncle | 1 0.01 31.23 Ganglioglioma | 1 0.01 31.24 Gastric cancer | 20 0.20 31.44 Gastric disorder | 41 0.41 31.85 Gastric infection | 1 0.01 31.86 Gastric mucosal lesion | 2 0.02 31.88 Gastric pH decreased | 1 0.01 31.89 Gastric ulcer | 28 0.28 32.17 Gastritis | 20 0.20 32.37 Gastritis prophylaxis | 6 0.06 32.43 Gastroenteritis viral | 1 0.01 32.44 Gastrointestinal disorder | 6 0.06 32.50 Gastrointestinal disorder therapy | 1 0.01 32.51 Gastrointestinal haemorrhage | 1 0.01 32.52 Gastrointestinal motility disorder | 13 0.13 32.65 Gastrointestinal pain | 3 0.03 32.68 Gastrointestinal stromal tumour | 2 0.02 32.70 Gastrooesophageal cancer | 3 0.03 32.73 Gastrooesophageal reflux disease | 629 6.29 39.02 General physical health deterioration | 1 0.01 39.03 Generalised anxiety disorder | 3 0.03 39.06 Generalised tonic-clonic seizure | 2 0.02 39.08 Genital infection | 1 0.01 39.09 Gestational diabetes | 1 0.01 39.10 Glaucoma | 10 0.10 39.20 Glioblastoma multiforme | 2 0.02 39.22 Glycogen storage disease type II | 1 0.01 39.23 Goitre | 2 0.02 39.25 Gout | 12 0.12 39.37 Gouty arthritis | 1 0.01 39.38 Granulomatosis with polyangiitis | 1 0.01 39.39 Groin pain | 1 0.01 39.40 Growth hormone deficiency | 3 0.03 39.43 Growth retardation | 1 0.01 39.44 HER-2 positive breast cancer | 5 0.05 39.49 HIV infection | 126 1.26 40.75 Haemoglobin abnormal | 1 0.01 40.76 Haemolytic uraemic syndrome | 6 0.06 40.82 Haemorrhage | 1 0.01 40.83 Haemorrhagic disorder | 1 0.01 40.84 Haemorrhoids | 4 0.04 40.88 Haemosiderosis | 1 0.01 40.89 Hair disorder | 2 0.02 40.91 Hallucination | 2 0.02 40.93 Head and neck cancer | 3 0.03 40.96 Headache | 32 0.32 41.28 Hearing impaired | 3 0.03 41.31 Heart disease congenital | 1 0.01 41.32 Heart rate increased | 4 0.04 41.36 Heart rate irregular | 1 0.01 41.37 Heart transplant | 6 0.06 41.43 Helicobacter gastritis | 4 0.04 41.47 Helicobacter infection | 4 0.04 41.51 Heparin-induced thrombocytopenia | 2 0.02 41.53 Hepatic pain | 1 0.01 41.54 Hepatitis C | 24 0.24 41.78 Hepatocellular carcinoma | 14 0.14 41.92 Hereditary angioedema | 25 0.25 42.17 Hernia | 6 0.06 42.23 Herpes simplex | 3 0.03 42.26 Herpes virus infection | 1 0.01 42.27 Herpes zoster | 7 0.07 42.34 Hiatus hernia | 34 0.34 42.68 Hiccups | 1 0.01 42.69 Hidradenitis | 5 0.05 42.74 Hip arthroplasty | 2 0.02 42.76 Hip fracture | 1 0.01 42.77 Hodgkin's disease | 72 0.72 43.49 Homocystinuria | 1 0.01 43.50 Hormone level abnormal | 2 0.02 43.52 Hormone replacement therapy | 665 6.65 50.17 Hormone therapy | 3 0.03 50.20 Hormone-refractory prostate cancer | 2 0.02 50.22 Hot flush | 3 0.03 50.25 Hyper IgD syndrome | 1 0.01 50.26 Hypercalcaemia | 1 0.01 50.27 Hyperchlorhydria | 26 0.26 50.53 Hypercholesterolaemia | 14 0.14 50.67 Hyperglycaemia | 1 0.01 50.68 Hyperhidrosis | 1 0.01 50.69 Hyperinsulinism | 1 0.01 50.70 Hyperkalaemia | 1 0.01 50.71 Hyperlipidaemia | 17 0.17 50.88 Hypersensitivity | 29 0.29 51.17 Hypersensitivity vasculitis | 1 0.01 51.18 Hypertension | 273 2.73 53.91 Hyperthyroidism | 1 0.01 53.92 Hypertonia | 4 0.04 53.96 Hypertonic bladder | 1 0.01 53.97 Hyperuricaemia | 7 0.07 54.04 Hypoaesthesia | 1 0.01 54.05 Hypocalcaemia | 1 0.01 54.06 Hypokalaemia | 4 0.04 54.10 Hypomagnesaemia | 2 0.02 54.12 Hypopituitarism | 5 0.05 54.17 Hypoproteinaemia | 1 0.01 54.18 Hypotension | 3 0.03 54.21 Hypothyroidism | 28 0.28 54.49 Hypovitaminosis | 2 0.02 54.51 Hysterectomy | 1 0.01 54.52 Ill-defined disorder | 2 0.02 54.54 Immune enhancement therapy | 2 0.02 54.56 Immune thrombocytopenic purpura | 13 0.13 54.69 Immunosuppressant drug level | 1 0.01 54.70 Immunosuppressant drug therapy | 3 0.03 54.73 Immunosuppression | 6 0.06 54.79 Impaired gastric emptying | 1 0.01 54.80 Impetigo | 2 0.02 54.82 Incontinence | 2 0.02 54.84 Increased upper airway secretion | 1 0.01 54.85 Infection | 12 0.12 54.97 Infection prophylaxis | 3 0.03 55.00 Inflammation | 7 0.07 55.07 Inflammatory bowel disease | 8 0.08 55.15 Influenza | 4 0.04 55.19 Influenza like illness | 1 0.01 55.20 Insomnia | 46 0.46 55.66 Insulin resistance | 1 0.01 55.67 Intentional overdose | 2 0.02 55.69 Intentional self-injury | 8 0.08 55.77 Intervertebral disc degeneration | 3 0.03 55.80 Intracranial pressure increased | 3 0.03 55.83 Intraocular pressure increased | 2 0.02 55.85 Intraocular pressure test abnormal | 1 0.01 55.86 Iron deficiency anaemia | 1 0.01 55.87 Iron metabolism disorder | 1 0.01 55.88 Iron overload | 5 0.05 55.93 Irritability | 5 0.05 55.98 Irritable bowel syndrome | 4 0.04 56.02 Ischaemia | 7 0.07 56.09 Ischaemic heart disease prophylaxis | 1 0.01 56.10 Ischaemic stroke | 3 0.03 56.13 Jaw fracture | 7 0.07 56.20 Joint dislocation | 1 0.01 56.21 Juvenile idiopathic arthritis | 3 0.03 56.24 Keratitis fungal | 7 0.07 56.31 Labour induction | 1 0.01 56.32 Large intestinal ulcer haemorrhage | 2 0.02 56.34 Laryngeal discomfort | 1 0.01 56.35 Laxative supportive care | 2 0.02 56.37 Leukaemia | 1 0.01 56.38 Limb discomfort | 3 0.03 56.41 Lipid metabolism disorder | 1 0.01 56.42 Lipids abnormal | 1 0.01 56.43 Lipids increased | 1 0.01 56.44 Liver disorder | 8 0.08 56.52 Liver transplant | 3 0.03 56.55 Liver transplant rejection | 1 0.01 56.56 Local anaesthesia | 1 0.01 56.57 Local swelling | 1 0.01 56.58 Localised infection | 1 0.01 56.59 Loss of consciousness | 1 0.01 56.60 Low density lipoprotein increased | 12 0.12 56.72 Lower respiratory tract infection | 2 0.02 56.74 Lower urinary tract symptoms | 2 0.02 56.76 Lung adenocarcinoma stage III | 1 0.01 56.77 Lung cancer metastatic | 4 0.04 56.81 Lung carcinoma cell type unspecified .. | 1 0.01 56.82 Lung disorder | 3 0.03 56.85 Lung neoplasm malignant | 3 0.03 56.88 Lupus nephritis | 7 0.07 56.95 Lupus-like syndrome | 5 0.05 57.00 Lymphocytic leukaemia | 2 0.02 57.02 Lymphoedema | 1 0.01 57.03 Lymphoma | 2 0.02 57.05 Lymphomatoid papulosis | 1 0.01 57.06 Macular degeneration | 2 0.02 57.08 Maculopathy | 1 0.01 57.09 Major depression | 2 0.02 57.11 Malaise | 3 0.03 57.14 Malignant melanoma | 9 0.09 57.23 Malnutrition | 1 0.01 57.24 Mania | 1 0.01 57.25 Mantle cell lymphoma | 7 0.07 57.32 Mantle cell lymphoma refractory | 1 0.01 57.33 Memory impairment | 1 0.01 57.34 Meniere's disease | 6 0.06 57.40 Meningitis pneumococcal | 1 0.01 57.41 Menometrorrhagia | 1 0.01 57.42 Menopausal disorder | 1 0.01 57.43 Menopausal symptoms | 16 0.16 57.59 Menopause | 3 0.03 57.62 Menorrhagia | 11 0.11 57.73 Menstrual cycle management | 9 0.09 57.82 Menstruation irregular | 2 0.02 57.84 Mental disorder | 12 0.12 57.96 Mesothelioma | 3 0.03 57.99 Metastases to bone | 11 0.11 58.10 Metastases to central nervous system | 1 0.01 58.11 Metastases to liver | 1 0.01 58.12 Metastases to lung | 1 0.01 58.13 Metastatic bronchial carcinoma | 1 0.01 58.14 Metastatic gastric cancer | 7 0.07 58.21 Metastatic glioma | 2 0.02 58.23 Metastatic malignant melanoma | 5 0.05 58.28 Metastatic renal cell carcinoma | 4 0.04 58.32 Methylenetetrahydrofolate reductase p.. | 4 0.04 58.36 Microalbuminuria | 1 0.01 58.37 Micropenis | 1 0.01 58.38 Microscopic polyangiitis | 1 0.01 58.39 Micturition disorder | 2 0.02 58.41 Migraine | 41 0.41 58.82 Migraine prophylaxis | 2 0.02 58.84 Migraine without aura | 3 0.03 58.87 Milk allergy | 1 0.01 58.88 Mineral supplementation | 11 0.11 58.99 Mood altered | 1 0.01 59.00 Mood swings | 5 0.05 59.05 Mucopolysaccharidosis II | 1 0.01 59.06 Mucosal inflammation | 1 0.01 59.07 Multiple allergies | 24 0.24 59.31 Multiple sclerosis | 371 3.71 63.02 Multiple sclerosis relapse | 1 0.01 63.03 Muscle disorder | 1 0.01 63.04 Muscle relaxant therapy | 8 0.08 63.12 Muscle spasms | 33 0.33 63.45 Muscle spasticity | 7 0.07 63.52 Muscular weakness | 1 0.01 63.53 Musculoskeletal discomfort | 1 0.01 63.54 Musculoskeletal pain | 5 0.05 63.59 Myalgia | 5 0.05 63.64 Mycobacterial infection | 2 0.02 63.66 Mycosis fungoides | 2 0.02 63.68 Myelodysplastic syndrome | 29 0.29 63.97 Myelofibrosis | 1 0.01 63.98 Myocardial infarction | 6 0.06 64.04 Myocardial ischaemia | 4 0.04 64.08 Nail disorder | 2 0.02 64.10 Narcolepsy | 7 0.07 64.17 Nasal congestion | 4 0.04 64.21 Nasopharyngitis | 1 0.01 64.22 Nausea | 51 0.51 64.73 Neck pain | 4 0.04 64.77 Neoplasm | 6 0.06 64.83 Neoplasm malignant | 4 0.04 64.87 Nephrogenic anaemia | 3 0.03 64.90 Nephrotic syndrome | 2 0.02 64.92 Nerve compression | 1 0.01 64.93 Nerve injury | 4 0.04 64.97 Nervous system disorder | 12 0.12 65.09 Nervousness | 1 0.01 65.10 Neuralgia | 7 0.07 65.17 Neuroendocrine carcinoma metastatic | 1 0.01 65.18 Neuroendocrine tumour | 6 0.06 65.24 Neuropathy peripheral | 13 0.13 65.37 Neutropenia | 6 0.06 65.43 Neutrophil count decreased | 1 0.01 65.44 Nicotine dependence | 1 0.01 65.45 Niemann-Pick disease | 1 0.01 65.46 Night sweats | 1 0.01 65.47 Non-Hodgkin's lymphoma | 9 0.09 65.56 Non-small cell lung cancer | 1 0.01 65.57 Non-small cell lung cancer stage IV | 2 0.02 65.59 Nutritional supplementation | 25 0.25 65.84 Obesity | 3 0.03 65.87 Obstruction | 1 0.01 65.88 Oedema | 9 0.09 65.97 Oedema peripheral | 3 0.03 66.00 Oesophageal adenocarcinoma | 6 0.06 66.06 Oesophageal carcinoma | 2 0.02 66.08 Oesophageal dilatation | 1 0.01 66.09 Oesophageal disorder | 7 0.07 66.16 Oesophageal haemorrhage | 1 0.01 66.17 Oesophageal spasm | 5 0.05 66.22 Oesophageal squamous cell carcinoma | 3 0.03 66.25 Oesophageal ulcer | 11 0.11 66.36 Oesophagitis | 1 0.01 66.37 Oestrogen replacement therapy | 1 0.01 66.38 Off label use | 11 0.11 66.49 Oligomenorrhoea | 1 0.01 66.50 Onychomycosis | 4 0.04 66.54 Optic neuritis | 1 0.01 66.55 Oral contraception | 9 0.09 66.64 Oral fungal infection | 1 0.01 66.65 Oral herpes | 2 0.02 66.67 Orchidectomy | 1 0.01 66.68 Organising pneumonia | 1 0.01 66.69 Oropharyngeal pain | 1 0.01 66.70 Osteitis | 2 0.02 66.72 Osteitis deformans | 3 0.03 66.75 Osteoarthritis | 7 0.07 66.82 Osteonecrosis | 1 0.01 66.83 Osteopenia | 20 0.20 67.03 Osteoporosis | 88 0.88 67.91 Osteoporosis postmenopausal | 4 0.04 67.95 Osteoporosis prophylaxis | 1 0.01 67.96 Otitis externa | 1 0.01 67.97 Otitis media | 2 0.02 67.99 Otitis media acute | 2 0.02 68.01 Ovarian cancer | 2 0.02 68.03 Ovarian cancer recurrent | 2 0.02 68.05 Ovarian cyst | 2 0.02 68.07 Ovarian endometrioid carcinoma | 2 0.02 68.09 Overdose | 1 0.01 68.10 Pain | 230 2.30 70.40 Pain in extremity | 12 0.12 70.52 Pain management | 4 0.04 70.56 Palpitations | 9 0.09 70.65 Pancreatic carcinoma | 2 0.02 70.67 Pancreatic carcinoma metastatic | 2 0.02 70.69 Pancreatic disorder | 2 0.02 70.71 Pancreatic neuroendocrine tumour | 4 0.04 70.75 Pancreatic neuroendocrine tumour meta.. | 1 0.01 70.76 Pancreatitis | 1 0.01 70.77 Pancytopenia | 2 0.02 70.79 Panic attack | 13 0.13 70.92 Paraesthesia | 4 0.04 70.96 Parkinson's disease | 13 0.13 71.09 Paroxysmal nocturnal haemoglobinuria | 177 1.77 72.86 Partial seizures | 13 0.13 72.99 Pelvic pain | 4 0.04 73.03 Pemphigoid | 2 0.02 73.05 Peptic ulcer | 3 0.03 73.08 Percutaneous coronary intervention | 1 0.01 73.09 Perioperative analgesia | 2 0.02 73.11 Peripheral swelling | 1 0.01 73.12 Peritoneal dialysis | 23 0.23 73.35 Persistent foetal circulation | 1 0.01 73.36 Personality disorder | 1 0.01 73.37 Phantom pain | 1 0.01 73.38 Pharyngitis | 7 0.07 73.45 Pharyngitis streptococcal | 1 0.01 73.46 Phytotherapy | 1 0.01 73.47 Pituitary tumour | 1 0.01 73.48 Plasma cell myeloma | 118 1.18 74.66 Platelet count | 1 0.01 74.67 Pneumocystis jirovecii pneumonia | 5 0.05 74.72 Pneumonia | 8 0.08 74.80 Pneumonia bacterial | 1 0.01 74.81 Pneumonia escherichia | 2 0.02 74.83 Pneumonitis | 3 0.03 74.86 Poisoning | 3 0.03 74.89 Pollakiuria | 1 0.01 74.90 Polyarthritis | 5 0.05 74.95 Polycystic ovaries | 2 0.02 74.97 Polymyalgia rheumatica | 1 0.01 74.98 Polyuria | 1 0.01 74.99 Poor peripheral circulation | 1 0.01 75.00 Portopulmonary hypertension | 1 0.01 75.01 Post herpetic neuralgia | 1 0.01 75.02 Post-traumatic epilepsy | 2 0.02 75.04 Post-traumatic stress disorder | 1 0.01 75.05 Postoperative analgesia | 1 0.01 75.06 Postoperative care | 8 0.08 75.14 Pregnancy | 7 0.07 75.21 Premedication | 65 0.65 75.86 Premenstrual dysphoric disorder | 6 0.06 75.92 Premenstrual syndrome | 9 0.09 76.01 Primary mediastinal large B-cell lymp.. | 6 0.06 76.07 Probiotic therapy | 1 0.01 76.08 Product used for unknown indication | 1,015 10.15 86.23 Productive cough | 1 0.01 86.24 Prolonged pregnancy | 1 0.01 86.25 Prophylaxis | 118 1.18 87.43 Prophylaxis against HIV infection | 1 0.01 87.44 Prophylaxis against bronchospasm | 1 0.01 87.45 Prophylaxis against diarrhoea | 1 0.01 87.46 Prophylaxis against gastrointestinal .. | 6 0.06 87.52 Prophylaxis against graft versus host.. | 6 0.06 87.58 Prophylaxis against transplant reject.. | 30 0.30 87.88 Prophylaxis of nausea and vomiting | 4 0.04 87.92 Prostate cancer | 8 0.08 88.00 Prostate cancer metastatic | 4 0.04 88.04 Prostatic disorder | 1 0.01 88.05 Prostatomegaly | 2 0.02 88.07 Proteinuria | 1 0.01 88.08 Prurigo | 1 0.01 88.09 Pruritus | 7 0.07 88.16 Psoriasis | 53 0.53 88.69 Psoriatic arthropathy | 28 0.28 88.97 Psychiatric symptom | 1 0.01 88.98 Psychopathic personality | 1 0.01 88.99 Psychotic disorder | 9 0.09 89.08 Pulmonary arterial hypertension | 78 0.78 89.86 Pulmonary embolism | 4 0.04 89.90 Pulmonary hypertension | 8 0.08 89.98 Pulmonary tuberculosis | 24 0.24 90.22 Pustular psoriasis | 2 0.02 90.24 Pyelonephritis acute | 1 0.01 90.25 Pyoderma | 2 0.02 90.27 Pyrexia | 7 0.07 90.34 Quadriplegia | 1 0.01 90.35 Rash | 9 0.09 90.44 Raynaud's phenomenon | 1 0.01 90.45 Rectal cancer | 4 0.04 90.49 Rectal cancer metastatic | 1 0.01 90.50 Reflux gastritis | 9 0.09 90.59 Relapsing-remitting multiple sclerosis | 37 0.37 90.96 Renal cell carcinoma | 14 0.14 91.10 Renal colic | 1 0.01 91.11 Renal disorder | 5 0.05 91.16 Renal failure | 1 0.01 91.17 Renal failure chronic | 4 0.04 91.21 Renal impairment | 1 0.01 91.22 Renal transplant | 24 0.24 91.46 Respiratory disorder | 4 0.04 91.50 Respiratory distress | 2 0.02 91.52 Restless legs syndrome | 13 0.13 91.65 Restlessness | 12 0.12 91.77 Rhabdomyosarcoma | 7 0.07 91.84 Rheumatic disorder | 1 0.01 91.85 Rheumatoid arthritis | 235 2.35 94.20 Rhinitis allergic | 4 0.04 94.24 Rhinorrhoea | 2 0.02 94.26 Right ventricular failure | 1 0.01 94.27 Rosacea | 1 0.01 94.28 Routine health maintenance | 6 0.06 94.34 Salivary hypersecretion | 1 0.01 94.35 Sarcoma | 1 0.01 94.36 Schizophrenia | 41 0.41 94.77 Schizophrenia, paranoid type | 2 0.02 94.79 Sciatica | 1 0.01 94.80 Scleroderma | 3 0.03 94.83 Scoliosis | 1 0.01 94.84 Seasonal allergy | 3 0.03 94.87 Secondary immunodeficiency | 1 0.01 94.88 Secondary progressive multiple sclero.. | 3 0.03 94.91 Sedation | 3 0.03 94.94 Sedative therapy | 2 0.02 94.96 Self injurious behaviour | 5 0.05 95.01 Senile osteoporosis | 4 0.04 95.05 Sepsis | 1 0.01 95.06 Septic shock | 4 0.04 95.10 Sinus arrhythmia | 1 0.01 95.11 Sinus disorder | 1 0.01 95.12 Sinusitis | 10 0.10 95.22 Sjogren's syndrome | 1 0.01 95.23 Skin disorder | 2 0.02 95.25 Sleep apnoea syndrome | 1 0.01 95.26 Sleep disorder | 52 0.52 95.78 Sleep disorder therapy | 3 0.03 95.81 Smoking cessation therapy | 8 0.08 95.89 Social phobia | 2 0.02 95.91 Somnolence | 2 0.02 95.93 Spinal column stenosis | 1 0.01 95.94 Spinal fracture | 8 0.08 96.02 Spinal pain | 2 0.02 96.04 Status epilepticus | 4 0.04 96.08 Stem cell transplant | 2 0.02 96.10 Stent placement | 4 0.04 96.14 Steroid therapy | 1 0.01 96.15 Stomatitis | 2 0.02 96.17 Stress | 2 0.02 96.19 Stress urinary incontinence | 1 0.01 96.20 Stupor | 3 0.03 96.23 Suicidal ideation | 1 0.01 96.24 Suicide attempt | 4 0.04 96.28 Supplementation therapy | 16 0.16 96.44 Supraventricular tachycardia | 2 0.02 96.46 Surgery | 1 0.01 96.47 Swelling | 3 0.03 96.50 Systemic lupus erythematosus | 8 0.08 96.58 Systemic sclerosis | 1 0.01 96.59 Tachycardia | 4 0.04 96.63 Tachyphrenia | 4 0.04 96.67 Teething | 1 0.01 96.68 Temporal lobe epilepsy | 1 0.01 96.69 Tension headache | 2 0.02 96.71 Testicular germ cell cancer | 4 0.04 96.75 Testis cancer | 1 0.01 96.76 Therapeutic embolisation | 2 0.02 96.78 Thinking abnormal | 1 0.01 96.79 Thrombocytopenia | 2 0.02 96.81 Thrombosis | 4 0.04 96.85 Thrombosis prophylaxis | 18 0.18 97.03 Thyroid cancer metastatic | 1 0.01 97.04 Thyroid disorder | 39 0.39 97.43 Thyroid haemorrhage | 1 0.01 97.44 Thyroid hormone replacement therapy | 1 0.01 97.45 Thyroidectomy | 1 0.01 97.46 Thyroiditis | 1 0.01 97.47 Thyroxine decreased | 1 0.01 97.48 Tinea cruris | 2 0.02 97.50 Tinea infection | 1 0.01 97.51 Tinnitus | 1 0.01 97.52 Tonsillitis | 1 0.01 97.53 Toxicity to various agents | 2 0.02 97.55 Tracheal cancer | 1 0.01 97.56 Transaminases increased | 1 0.01 97.57 Transient ischaemic attack | 2 0.02 97.59 Transitional cell carcinoma | 2 0.02 97.61 Transplant | 1 0.01 97.62 Treatment noncompliance | 1 0.01 97.63 Tremor | 8 0.08 97.71 Trigeminal neuralgia | 2 0.02 97.73 Tuberculosis | 8 0.08 97.81 Tumour associated fever | 1 0.01 97.82 Tumour lysis syndrome | 1 0.01 97.83 Type 1 diabetes mellitus | 8 0.08 97.91 Type 2 diabetes mellitus | 84 0.84 98.75 Type IIa hyperlipidaemia | 1 0.01 98.76 Tyrosinaemia | 1 0.01 98.77 Ulcer | 19 0.19 98.96 Ulcer haemorrhage | 8 0.08 99.04 Underweight | 1 0.01 99.05 Unevaluable event | 5 0.05 99.10 Upper respiratory tract infection | 2 0.02 99.12 Urinary incontinence | 3 0.03 99.15 Urinary tract infection | 12 0.12 99.27 Urosepsis | 4 0.04 99.31 Urticaria | 2 0.02 99.33 Uterine cancer | 1 0.01 99.34 Uveitis | 9 0.09 99.43 Varicella | 1 0.01 99.44 Vascular graft | 1 0.01 99.45 Vasculitis | 1 0.01 99.46 Ventricular arrhythmia | 1 0.01 99.47 Ventricular tachycardia | 2 0.02 99.49 Vertigo | 1 0.01 99.50 Viral cardiomyopathy | 1 0.01 99.51 Visceral leishmaniasis | 3 0.03 99.54 Vitamin B12 deficiency | 2 0.02 99.56 Vitamin D | 2 0.02 99.58 Vitamin D decreased | 1 0.01 99.59 Vitamin D deficiency | 7 0.07 99.66 Vitamin supplementation | 13 0.13 99.79 Vomiting | 11 0.11 99.90 Vulvovaginal dryness | 6 0.06 99.96 Weight decreased | 1 0.01 99.97 Wheezing | 1 0.01 99.98 White matter lesion | 1 0.01 99.99 X-linked chromosomal disorder | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 6 Apr 2017